{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:34:49Z","timestamp":1777268089378,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012624"],"award-info":[{"award-number":["2023A1515012624"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515013260"],"award-info":[{"award-number":["2024A1515013260"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220530145210024"],"award-info":[{"award-number":["JCYJ20220530145210024"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["ZDSYS20230626091203007"],"award-info":[{"award-number":["ZDSYS20230626091203007"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jacl.2024.07.004","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T07:05:31Z","timestamp":1721199931000},"page":"e787-e796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genetic association analyses highlight apolipoprotein B as a determinant of chronic kidney disease in patients with type 2 diabetes"],"prefix":"10.1016","volume":"18","author":[{"given":"Zhenqian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2795-714X","authenticated-orcid":false,"given":"Guozhi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jacl.2024.07.004_bib0001","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.jacl.2024.07.004_bib0002","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jdi.13355","article-title":"Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: estimates from Global Burden of Disease 2017","volume":"12","author":"Li","year":"2021","journal-title":"J Diabetes Investig"},{"issue":"11","key":"10.1016\/j.jacl.2024.07.004_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112832","article-title":"Metabolomics in Diabetes and Diabetic Complications: insights from Epidemiological Studies","volume":"10","author":"Jin","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jacl.2024.07.004_bib0004","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40842-015-0001-9","article-title":"Management of diabetes mellitus in patients with chronic kidney disease","volume":"1","author":"Hahr","year":"2015","journal-title":"Clin Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.jacl.2024.07.004_bib0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000479874","article-title":"Crosstalk of hyperglycemia and dyslipidemia in diabetic kidney disease","volume":"3","author":"Su","year":"2017","journal-title":"Kidney Dis (Basel)"},{"issue":"11","key":"10.1016\/j.jacl.2024.07.004_bib0006","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2019.07.037","article-title":"Impact of LDL cholesterol on microvascular versus macrovascular disease: a Mendelian randomization study","volume":"74","author":"Emanuelsson","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacl.2024.07.004_bib0007","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.ajkd.2017.06.011","article-title":"HDL Cholesterol, LDL cholesterol, and triglycerides as risk factors for CKD: a mendelian randomization study","volume":"71","author":"Lanktree","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.jacl.2024.07.004_bib0008","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40265-013-0023-5","article-title":"Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management","volume":"73","author":"Chehade","year":"2013","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.jacl.2024.07.004_bib0009","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/CIRCULATIONAHA.113.002529","article-title":"Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries","volume":"129","author":"Sacks","year":"2014","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jacl.2024.07.004_bib0010","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2337\/dc16-1246","article-title":"Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative","volume":"39","author":"Russo","year":"2016","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jacl.2024.07.004_bib0011","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.ajkd.2007.11.010","article-title":"A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study","volume":"51","author":"Xu","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"21","key":"10.1016\/j.jacl.2024.07.004_bib0012","doi-asserted-by":"crossref","first-page":"E729","DOI":"10.1503\/cmaj.230093","article-title":"Statin initiation and risk of incident kidney disease in patients with diabetes","volume":"195","author":"Zhou","year":"2023","journal-title":"CMAJ"},{"issue":"7","key":"10.1016\/j.jacl.2024.07.004_bib0013","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.2337\/diacare.26.7.2150","article-title":"Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study","volume":"26","author":"Bruno","year":"2003","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jacl.2024.07.004_bib0014","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1523-1755.2005.00235.x","article-title":"Lipid abnormalities associated with urinary albumin excretion rate in Taiwanese type 2 diabetic patients","volume":"67","author":"Tseng","year":"2005","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.jacl.2024.07.004_bib0015","first-page":"3546","article-title":"Remnant Cholesterol and Cardiovascular Mortality in Patients With Type 2 Diabetes and Incident Diabetic Nephropathy","volume":"106","author":"Yu","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"27","key":"10.1016\/j.jacl.2024.07.004_bib0016","doi-asserted-by":"crossref","first-page":"e4007","DOI":"10.1097\/MD.0000000000004007","article-title":"Predictors of chronic kidney disease in type 2 diabetes: a longitudinal study from the AMD Annals initiative","volume":"95","author":"De Cosmo","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.jacl.2024.07.004_bib0017","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in >300,000 individuals","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.jacl.2024.07.004_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.jacl.2024.07.004_bib0019","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040501","article-title":"Mendelian randomization: concepts and scope","volume":"12","author":"Richmond","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jacl.2024.07.004_bib0020","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jacl.2024.07.004_bib0021","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/jama.2019.22241","article-title":"Predictive accuracy of a polygenic risk score-enhanced prediction model vs a clinical risk score for coronary artery disease","volume":"323","author":"Elliott","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2024.07.004_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100528","article-title":"Causal association of blood lipids with all-cause and cause-specific mortality risk: a Mendelian randomization study","author":"Lu","year":"2024","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1016\/j.jacl.2024.07.004_bib0023","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.jacl.2024.07.004_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"7726","key":"10.1016\/j.jacl.2024.07.004_bib0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jacl.2024.07.004_bib0026","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/db20-0602","article-title":"Stratification of type 2 diabetes by age of diagnosis in the UK biobank reveals subgroup-specific genetic associations and causal risk profiles","volume":"70","author":"Noordam","year":"2021","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.jacl.2024.07.004_bib0027","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s00125-022-05759-6","article-title":"Assessment of the bi-directional relationship between blood mitochondrial DNA copy number and type 2 diabetes mellitus: a multivariable-adjusted regression and Mendelian randomisation study","volume":"65","author":"Wang","year":"2022","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.jacl.2024.07.004_bib0028","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2337\/dc22-0177","article-title":"Microvascular burden and incident heart failure among middle-aged and older adults with type 1 or type 2 diabetes","volume":"45","author":"Li","year":"2022","journal-title":"Diabetes Care"},{"issue":"16","key":"10.1016\/j.jacl.2024.07.004_bib0029","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1093\/hmg\/ddad093","article-title":"Stratified genome-wide association analysis of type 2 diabetes reveals subgroups with genetic and environmental heterogeneity","volume":"32","author":"Christiansen","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.jacl.2024.07.004_bib0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jacc.2021.05.004","article-title":"Cardiovascular and kidney outcomes across the glycemic spectrum: insights from the UK Biobank","volume":"78","author":"Honigberg","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.07.004_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117394","article-title":"Investigating linear and nonlinear associations of LDL cholesterol with incident chronic kidney disease, atherosclerotic cardiovascular disease and all-cause mortality: a prospective and Mendelian randomization study","volume":"387","author":"Wang","year":"2023","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.jacl.2024.07.004_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001547","article-title":"Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation","volume":"20","author":"Richardson","year":"2022","journal-title":"PLoS Biol"},{"issue":"4","key":"10.1016\/j.jacl.2024.07.004_bib0033","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/gepi.22041","article-title":"Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization","volume":"41","author":"Staley","year":"2017","journal-title":"Genet Epidemiol"},{"issue":"12","key":"10.1016\/j.jacl.2024.07.004_bib0034","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.jacl.2024.07.004_bib0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s43657-022-00057-y","article-title":"Plasma lipidomic subclasses and risk of hypertension in middle-aged and elderly Chinese","volume":"2","author":"Niu","year":"2022","journal-title":"Phenomics"},{"issue":"6","key":"10.1016\/j.jacl.2024.07.004_bib0036","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1016\/j.clnu.2020.12.042","article-title":"Habitual coffee intake and plasma lipid profile: evidence from UK Biobank","volume":"40","author":"Zhou","year":"2021","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.jacl.2024.07.004_bib0037","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41588-020-00757-z","article-title":"Genetics of 35 blood and urine biomarkers in the UK Biobank","volume":"53","author":"Sinnott-Armstrong","year":"2021","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.jacl.2024.07.004_bib0038","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jama.2018.20045","article-title":"Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease","volume":"321","author":"Ference","year":"2019","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jacl.2024.07.004_bib0039","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S2213-8587(17)30313-3","article-title":"Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial","volume":"5","author":"Sabatine","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"10.1016\/j.jacl.2024.07.004_bib0040","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.2337\/diacare.26.10.2965","article-title":"Apolipoprotein B is an independent risk factor for microalbuminuria in Taiwanese patients with type 2 diabetes","volume":"26","author":"Tseng","year":"2003","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jacl.2024.07.004_bib0041","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0009-9120(98)00101-5","article-title":"Increased plasma apolipoprotein B-containing lipoproteins associated with increased urinary albumin within the microalbuminuria range in type 2 diabetes","volume":"32","author":"Hegele","year":"1999","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jacl.2024.07.004_bib0042","article-title":"Susceptibility of ApoB and PCSK9 genetic polymorphisms to diabetic kidney disease among chinese diabetic patients","volume":"8","author":"Ma","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"10.1016\/j.jacl.2024.07.004_bib0043","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1194\/jlr.M078204","article-title":"Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-\u03b2 inhibition","volume":"58","author":"Wilson","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2024.07.004_bib0044","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/IJNRD.S101808","article-title":"Dyslipidemia in patients with chronic kidney disease: etiology and management","volume":"10","author":"Mikolasevic","year":"2017","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"2","key":"10.1016\/j.jacl.2024.07.004_bib0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacl.2021.12.004","article-title":"Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins","volume":"16","author":"Hammad","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"4","key":"10.1016\/j.jacl.2024.07.004_bib0046","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/joim.12026","article-title":"Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study","volume":"273","author":"M\u00e4kinen","year":"2013","journal-title":"J Intern Med"},{"issue":"7","key":"10.1016\/j.jacl.2024.07.004_bib0047","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa173","article-title":"Plasma metabolomics identifies markers of impaired renal function: a meta-analysis of 3089 persons with type 2 diabetes","volume":"105","author":"Tofte","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jacl.2024.07.004_bib0048","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00041433-199408000-00002","article-title":"Atherosclerosis and arterial influx of lipoproteins","volume":"5","author":"Nordestgaard","year":"1994","journal-title":"Curr Opin Lipidol"},{"issue":"7347","key":"10.1016\/j.jacl.2024.07.004_bib0049","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jacl.2024.07.004_bib0050","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.108.181040","article-title":"Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2","volume":"104","author":"Bae","year":"2009","journal-title":"Circ Res"},{"issue":"4 Suppl 2","key":"10.1016\/j.jacl.2024.07.004_bib0051","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1681\/ASN.2005121320","article-title":"Lipids and renal disease","volume":"17","author":"Trevisan","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.jacl.2024.07.004_bib0052","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00125-009-1597-z","article-title":"Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes","volume":"53","author":"Lin","year":"2010","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.jacl.2024.07.004_bib0053","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.numecd.2008.11.003","article-title":"Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes","volume":"19","author":"Zoppini","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.jacl.2024.07.004_bib0054","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12944-019-0970-2","article-title":"Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China","volume":"18","author":"Yang","year":"2019","journal-title":"Lipids Health Dis"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T11:33:16Z","timestamp":1732620796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287424002137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1933287424002137"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.07.004","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic association analyses highlight apolipoprotein B as a determinant of chronic kidney disease in patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}